Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report.
Viviani L, Reid K, Gastineau T, Milne C, Smith D, Levis R, Lei D, van Ooij M, Gilbert PA, Vandeputte J, Xie J, Madhuri L, Shaid S, Kubiak V, Suri R, Mizukami T, Shirasaki Y, Li X, Zhou YY, Trapkova A, Goel S, Prakash J, Subagio AA, Suwarni E, Jung KJ, Sanyal G, Das P, Coppens E, Wright D, Peng Z, Northeved H, Jungbäck C, Kirpitchenok T, Del Pace L, Seo B, Poojary B, Ottoni A. Viviani L, et al. Among authors: gilbert pa. Biologicals. 2022 Jul;78:17-26. doi: 10.1016/j.biologicals.2022.06.003. Epub 2022 Jul 12. Biologicals. 2022. PMID: 35840492 Free PMC article.
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Hasso-Agopsowicz M, Crowcroft N, Biellik R, Gregory CJ, Menozzi-Arnaud M, Amorij JP, Gilbert PA, Earle K, Frivold C, Jarrahian C, Mvundura M, Mistilis JJ, Durrheim DN, Giersing B. Hasso-Agopsowicz M, et al. Among authors: gilbert pa. Front Public Health. 2022 Mar 2;10:809675. doi: 10.3389/fpubh.2022.809675. eCollection 2022. Front Public Health. 2022. PMID: 35309224 Free PMC article. Review.
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
Dul M, Alali M, Ameri M, Burke MD, Craig CM, Creelman BP, Dick L, Donnelly RF, Eakins MN, Frivold C, Forster AH, Gilbert PA, Henke S, Henry S, Hunt D, Lewis H, Maibach HI, Mistilis JJ, Park JH, Prausnitz MR, Robinson DK, Hernandez CAR, Ross C, Shin J, Speaker TJ, Taylor KM, Zehrung D, Birchall JC, Jarrahian C, Coulman SA. Dul M, et al. Among authors: gilbert pa. J Control Release. 2023 Sep;361:236-245. doi: 10.1016/j.jconrel.2023.07.001. Epub 2023 Aug 8. J Control Release. 2023. PMID: 37437849 Free article.
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Scarnà T, Menozzi-Arnaud M, Friede M, DeMarco K, Plopper G, Hamer M, Chakrabarti A, Gilbert PA, Jarrahian C, Mistilis J, Hesselink R, Gandrup-Marino K, Amorij JP, Giersing B. Scarnà T, et al. Among authors: gilbert pa. Expert Opin Drug Deliv. 2023 Mar;20(3):315-322. doi: 10.1080/17425247.2023.2168641. Epub 2023 Jan 27. Expert Opin Drug Deliv. 2023. PMID: 36649573
70 results